Cleared Abbreviated

BIPAP A 30 VENTILATORY SUPPORT SYSTEM (K113053) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K113053 · Respironics, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
111d
Days
Class 2
Risk

K113053 is an FDA 510(k) clearance for the BIPAP A 30 VENTILATORY SUPPORT SYSTEM. Classified as Ventilator, Continuous, Non-life-supporting (product code MNS), Class II - Special Controls.

Submitted by Respironics, Inc. (Murrysville, US). The FDA issued a Cleared decision on February 1, 2012 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5895 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Respironics, Inc. devices

Submission Details

510(k) Number K113053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 2011
Decision Date February 01, 2012
Days to Decision 111 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 140d · This submission: 111d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MNS Ventilator, Continuous, Non-life-supporting
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5895
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - MNS Ventilator, Continuous, Non-life-supporting

All 19
Devices cleared under the same product code (MNS) and FDA review panel - the closest regulatory comparables to K113053.
BPAP System
K213169 · BMC Medical Co., Ltd. · Dec 2022
ReddyPort NIV Access Elbow
K171827 · Smd Manufacturing, LLC · Jan 2018
Juno VPAP ST-A
K161492 · Resmed, Ltd. · Jan 2017
BIPAP AVAPS VENTILATORY SUPPORT SYSTEM
K102465 · Respironics, Inc. · Mar 2011
BIPAP SYNCHRONY 2 WITH AF531 FULL FACE MASK
K101130 · Respironics, Inc. · Sep 2010
BIPAP AVAPS VENTILATORY SUPPORT SYSTEM
K092818 · Respironics, Inc. · Jan 2010